Abbott to Pay Nearly $385 Million to Settle Infant Formula Contamination Litigation
Abbott Laboratories agreed to pay almost $385 million to settle litigation tied to bacterial contamination at a U.S. production facility that previously contributed to a nationwide shortage of baby formula.